Back to Browse Journals » Clinical Ophthalmology » Volume 7

Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma

Authors Lonngi M, Houston SK, Murray TG, Sisk RA, Decatur CL, Cavalcante M, Markoe AM

Published Date February 2013 Volume 2013:7 Pages 427—435


Received 27 July 2012, Accepted 14 September 2012, Published 27 February 2013

Marcela Lonngi,1 Samuel K Houston,1 Timothy G Murray,1–3 Robert A Sisk,4 Christina L Decatur,1 Milena Cavalcante,1 Arnold M Markoe3

1Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, FL, USA; 2Murray Ocular Oncology and Retina, Miami, FL, USA; 3Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL, USA; 4Department of Ophthalmology, Cincinnati Eye Institute, Cincinnati, OH, USA

Purpose: To analyze functional and anatomical outcomes following 23/25+ gauge microincisional pars plana vitrectomy surgery (MIVS) in patients with radiation-related retinal detachment after successful 125-iodine (I-125) brachytherapy treatment for malignant uveal melanoma.
Patients and methods: Retrospective case series of 102 consecutive eyes of 102 patients with history of uveal melanoma treated with I-125 brachytherapy that underwent MIVS at the Bascom Palmer Eye Institute. All cases were evaluated for surgical complications and local tumor control. Extended follow-up included Snellen’s best-corrected visual acuity, intraocular pressure evaluation, quantitative echography, indirect ophthalmoscopy, and fundus imaging with optical coherence tomography/wide-field photography.
Results: All patients had radiation-related complications, including retinal detachment (102 eyes), vasculopathy (91 eyes), optic neuropathy (32 eyes), and/or vitreous hemorrhage (8 eyes). Sixty-seven patients had vitreoretinal traction. Average follow-up after MIVS was 19.5 months, and from plaque removal was 57.7 months. Interval from plaque to MIVS was 38.1 months. Initial visual acuity was 20/258, which improved to 20/101 at 1 month, 20/110 at 3 months, 20/116 at 6 months, and 20/113 at 12 months (P < 0.05). No eyes required enucleation. Melanoma-related mortality was 0.9% (1/102). There was no intra- or extraocular tumor dissemination, and no tumor recurrence.
Conclusion: MIVS was effective in improving visual function and anatomy in patients with radiation-related retinal detachment. Tumors decreased in size and there was no evidence of recurrence or tumor dissemination. This combined procedure addresses the modifiable causes of visual loss in patients with previously treated malignant uveal melanoma and has the potential to enhance their visual function.

Keywords: retinal detachment, vitrectomy, melanoma, radiation-related complications

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

A characteristic optic disc appearance associated with myopia in subjects with Graves' ophthalmopathy and in subjects with primary open-angle glaucoma

Yamazaki S, Inoue R, Tsuboi T, Kozaki A, Inoue T, Inoue T, Inoue Y

Clinical Ophthalmology 2013, 7:47-53

Published Date: 7 January 2013

Clinical manifestations of optic pit maculopathy as demonstrated by spectral domain optical coherence tomography

Tzu JH, Flynn Jr HW, Berrocal AM, Smiddy WE, Murray TG, Fisher YL

Clinical Ophthalmology 2013, 7:167-172

Published Date: 18 January 2013

Deposit buildup on prosthetic eye material (in vitro) and its effect on surface wettability

Pine KR, Sloan B, Han KYI, Swift S, Jacobs RJ

Clinical Ophthalmology 2013, 7:313-319

Published Date: 13 February 2013

Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulations

Fukuda M, Shibata S, Shibata N, Hagihara K, Yaguchi H, Osada H, Takahashi N, Kubo E, Sasaki H

Clinical Ophthalmology 2013, 7:515-520

Published Date: 12 March 2013

Can intramuscular corticosteroid injection cause nonarteritic anterior ischemic optic neuropathy?

Bakbak B, Ozturk BT, Gedik S, Koktekir BE, Gonul S

Clinical Ophthalmology 2013, 7:633-635

Published Date: 26 March 2013

Long-term retinal nerve fiber layer changes following nonarteritic anterior ischemic optic neuropathy

Dotan G, Goldstein M, Kesler A, Skarf B

Clinical Ophthalmology 2013, 7:735-740

Published Date: 17 April 2013

Optic disc size and progression of visual field damage in patients with normal-tension glaucoma

Hayamizu F, Yamazaki Y, Nakagami T, Mizuki K

Clinical Ophthalmology 2013, 7:807-813

Published Date: 3 May 2013

Choroidal thinning in high myopia measured by optical coherence tomography

Ikuno Y, Fujimoto S, Jo Y, Asai T, Nishida K

Clinical Ophthalmology 2013, 7:889-893

Published Date: 15 May 2013